Search

Showing 11 - 20 of 534 results.

Overview

LEARN MORE: DIAGNOSIS TREATMENT AS is a progressive disease. While patients with AS may initially be asymptomatic, further progression is typically associated with symptoms and poor…
Guidelines

Asymptomatic patients Intervention is recommended in asymptomatic patients with severe aortic stenosis and systolic LV dysfunction (LVEF <50%) without another cause (class I, B). …
Options

As recommended in the 2020 American College of Cardiology/American Heart Association (ACC/AHA) and 2021 ESC/EACTS guidelines,38,39 patients with TR should be managed by a multidisciplinary heart…
Diagnosis

Most early-stage TR is clinically silent,1 and even with severe TR, some patients may be asymptomatic.27 In patients who become symptomatic of TR, the prevalence and severity of the symptoms are…
Overview

TRI-SCORE RISK SCORE MODEL FOR ISOLATED TRICUSPID VALVE SURGERY Secondary TR arising from RV remodelling can be classified in three progressive stages26 Initial Right Ventricular (RV)…
Overview

Two Types of Mitral Regurgitation 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a…
Surgical Repair or Replacement

PRIMARY MITRAL REGURGITATION (PMR) Surgical repair of the mitral valve is the gold standard treatment for PMR in patients with evidence of left ventricular (LV) dysfunction or dilation.6,17,22…
Diagnosis

MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be…
ESC GUIDELINES 2025 – ABBOTT AT ESC

ESC Congress 2025 Shaping the Future of Structural Heart Therapies ESC Congress 2025 delivered powerful momentum in TEER and TAVI, with key updates that are now shaping clinical practice. Dive…
Overview

WATCH ON-DEMAND: PCR LV 2025 SYMPOSIUM ESC 2025 VANTAGE STUDY Imaging Webinars 2025 TAVI Webinars 2025 TAVI SUMMIT 2025 WATCH THE LIVE…